Quick Answer
10x Genomics, Inc. reported Total Assets of $1.04 billion for fiscal year 2025.
10x Genomics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.04B | +13.4% |
| 2024 | $918.64M | -4.8% |
| 2023 | $965.14M | -6.2% |
| 2022 | $1.03B | +1.0% |
| 2021 | $1.02B | +9.6% |
| 2020 | $929.34M | +53.4% |
| 2019 | $605.92M | +387.4% |
| 2018 | $124.31M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.03B | +9.6% | +4.8% |
| June 30, 2025 | $979.97M | +5.4% | +8.5% |
| March 31, 2025 | $903.39M | -2.1% | -1.7% |
| December 31, 2024 | $918.64M | -4.8% | -2.0% |
| September 30, 2024 | $937.79M | -1.1% | +0.9% |
| June 30, 2024 | $929.67M | -6.1% | +0.7% |
| March 31, 2024 | $922.91M | -9.0% | -4.4% |
| December 31, 2023 | $965.14M | -6.2% | +1.8% |
- 10x Genomics, Inc. showed an increase of +13.4% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, 10x Genomics, Inc.’s total assets has grown by 737.7% (from $124.31 million to $1.04 billion).
- The most recent figure is from 10x Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: